Endomucin regulates vascular endothelial growth factor (VEGF) Receptor 2 (VEGFR2) Endocytosis

被引:0
作者
LeBlanc, M. [1 ]
Hu, Z. [1 ]
Saez-Torres, K. [1 ]
Saint-Geniez, M. [1 ]
Ng, E. [1 ]
D'Amore, P. [1 ]
机构
[1] Schepens Eye Res Inst Mass Eye & Ear, Boston, MA USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CIRSP5
引用
收藏
页码:2420 / 2421
页数:2
相关论文
共 50 条
[31]   Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway [J].
Sun, Qiurong ;
Zhang, Taiyang ;
Xiao, Qingchun ;
Mei, Bingxin ;
Zhang, Xingwang .
BIOENGINEERED, 2022, 13 (03) :6500-6508
[32]   Localization and control of expression of vascular endothelial growth factor-A (VEGF-A) and the VEGFR2 receptor in fetal sheep small intestine. [J].
Smith, GC ;
Holmes, KL ;
Charnock-Jones, S ;
Giussani, DA ;
Fowden, AL ;
Forhead, AJ ;
Licence, D .
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2006, 13 (02) :100A-100A
[33]   Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy [J].
Kim, D. H. ;
Xu, W. ;
Kamel-Reid, S. ;
Liu, X. ;
Jung, C. W. ;
Kim, S. ;
Lipton, J. H. .
ANNALS OF ONCOLOGY, 2010, 21 (06) :1179-1188
[34]   The Usefulness of Assessment the Serum Concentrations of Vascular Endothelial Growth Factor (VEGF) and Its Soluble Receptor Type 2 (VEGFR2) in Patients with Neuroendocrine Neoplasm (NEN) [J].
Rosiek, V. ;
Kos-Kudla, B. ;
Zemczak, A. .
NEUROENDOCRINOLOGY, 2016, 103 :51-51
[35]   Vascular endothelial growth factor (VEGF) 165 increases vascular development in perinatal rat ovary while inhibition of VEGF receptor 2 (VEGFR2) does not alter vascular development or follicle progression. [J].
Ten Broeck, Robin A. ;
Clopton, Debra T. ;
Baltes, Michelle M. ;
Bott, Rebecca C. ;
Cupp, Andrea S. .
BIOLOGY OF REPRODUCTION, 2006, :77-77
[36]   Genes Encoding Vascular Endothelial Growth Factor A (VEGF-A) and VEGF Receptor 2 (VEGFR-2) and Risk for Bronchopulmonary Dysplasia [J].
Mahlman, Mari ;
Huusko, Johanna M. ;
Karjalainen, Minna K. ;
Kaukola, Tuula ;
Marttila, Riitta ;
Ojaniemi, Marja ;
Haataja, Ritva ;
Lavoie, Pascal M. ;
Ramet, Mika ;
Hallman, Mikko .
NEONATOLOGY, 2015, 108 (01) :53-59
[37]   Author Correction: Endomucin knockdown inhibits VEGF-induced endothelial cell migration, growth, and morphogenesis by modulating VEGFR2 signaling [J].
Cindy Park-Windhol ;
Yin Shan Ng ;
Jinling Yang ;
Vincent Primo ;
Magali Saint-Geniez ;
Patricia A. D’Amore .
Scientific Reports, 13
[38]   In vivo imaging of vascular endothelial growth factor receptor-2 (VEGFR2) expression using biparatopic affibody construct [J].
Mitran, Bogdan ;
Guler, Rezan ;
Roche, Frank ;
Lindstrom, Elin ;
Fleetwood, Filippa ;
Claesson-Welsh, Lena ;
Selvaraju, Ram Kumar ;
Tolmachev, Vladimir ;
Stahl, Stefan ;
Lofblom, John ;
Orlova, Anna .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 :S178-S178
[39]   Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis [J].
Lin, Yuh-Charn ;
Chao, Tsu-Yi ;
Yeh, Chi-Tai ;
Roffler, Steve R. ;
Kannagi, Reiji ;
Yang, Ruey-Bing .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (01) :144-+
[40]   Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model [J].
Lee, Debbie J. ;
Lyshchik, Andrej ;
Huamani, Jessica ;
Hallahan, Dennis E. ;
Fleischer, Arthur C. .
JOURNAL OF ULTRASOUND IN MEDICINE, 2008, 27 (06) :855-866